J&J Ethicon’s Gynecare TVT off the Australian TGA Register

Introduction

A recent report stated that J&J’s Ethicon, Inc. has failed to meet a regulatory deadline set forth by Australian Therapeutics Good Administration (TGA) for updating the products’ “instructions for use” for its Gynecare TVT, a pelvic mesh device, which was set as January 17th. This has resulted in the withdrawing of the product from the Australian market and the product no longer appears on the TGA Register. However, the company clarified that this was not a product recall and required no action by those who had received the product.

Comments

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

J&J Ethicon’s Gynecare TVT off the Australian TGA Register